CNNMoney.com »

Market Tracker

06/09 5:38pm ET

Dow
+43.17
33,876.78
+0.13%
S&P 500
+4.93
4,298.86
+0.11%
Nasdaq
+20.62
13,259.14
+0.16%
Russell 2000
-15.07
1,865.71
-0.80%
FTSE 100
-44.92
7,562.36
-0.59%
DAX
-40.16
15,949.84
-0.25%

Novo Nordisk A/S (NYSE:NVO)

158.07

Delayed Data

As of Jun 09

-1.38 / -0.87%

Today’s Change

95.02

Today|||52-Week Range

172.97

+16.79%

Year-to-Date

Latest NVO News | Press Releases

Novartis (NVS) Sandoz Presents Standalone Growth Strategy Jun 09 / Zacks.com - Paid Partner Content	Novo Nordisk (NVO) Gears Up to Acquire BIOCORP for 154M Euros Jun 05 / Zacks.com - Paid Partner Content
FDA Accepts Vertex (VRTX), CRISPR's BLA Filings for Exa-Cel Jun 09 / Zacks.com - Paid Partner Content	AstraZeneca (AZN) Anticoagulant Drug Study Meets Efficacy Goal Jun 05 / Zacks.com - Paid Partner Content
3 Reasons Why Growth Investors Shouldn't Overlook Novo Nordisk (NVO) Jun 09 / Zacks.com - Paid Partner Content	Best Momentum Stocks to Buy for June 5th Jun 05 / Zacks.com - Paid Partner Content
Merck's (MRK) Keytruda for Liver Cancer to Undergo FDA Review Jun 09 / Zacks.com - Paid Partner Content	Is Novo Nordisk (NVO) Stock Outpacing Its Medical Peers This Year? Jun 05 / Zacks.com - Paid Partner Content
Novo Nordisk (NVO) Outpaces Stock Market Gains: What You Should Know Jun 08 / Zacks.com - Paid Partner Content	Novo Nordisk's Smash-Hit Drug Could Become Even More Profitable. Here's Why. Jun 05 / MotleyFool.com - Paid Partner Content
FibroGen (FGEN) Pamrevlumab Fails DMD Study, Stock Down 8% Jun 08 / Zacks.com - Paid Partner Content	New Strong Buy Stocks for June 5th Jun 05 / Zacks.com - Paid Partner Content
Intercept (ICPT) Announces Positive Data From PBC Study Jun 07 / Zacks.com - Paid Partner Content	Could Pfizer Have an Ozempic Killer on the Way? Jun 05 / MotleyFool.com - Paid Partner Content
Merck (MRK) Sues US Government to Halt Drug Price Negotiations Jun 07 / Zacks.com - Paid Partner Content	Zacks Industry Outlook Highlights Eli Lilly, Johnson & Johnson, Novo Nordisk, Roche and Novartis Jun 01 / Zacks.com - Paid Partner Content
Bausch (BHC) Down on Tentative Approval to Xifaxan ANDA Jun 07 / Zacks.com - Paid Partner Content	Pfizer (PFE) Posts Upbeat Data From Hemophilia Drug Study May 31 / Zacks.com - Paid Partner Content
Novo Nordisk and Golden Entertainment have been highlighted as Zacks Bull and Bear of the Day Jun 07 / Zacks.com - Paid Partner Content	Got $5,000? These 2 Stocks Could Be Bargain Buys for 2023 and Beyond. May 31 / MotleyFool.com - Paid Partner Content
Bull of the Day: Novo Nordisk (NVO) Jun 07 / Zacks.com - Paid Partner Content	Does Pfizer Have a Weight-Loss Pill That's Better Than Ozempic? May 31 / MotleyFool.com - Paid Partner Content
Ozempic is taking China by storm. Drugmakers are scrambling to boost supplies Jun 06 / CNN.com	This Could Be Novo Nordisk's Next Big Weight-Loss Product May 31 / MotleyFool.com - Paid Partner Content
Why Novo Nordisk Stock Bumped Higher Today Jun 06 / MotleyFool.com - Paid Partner Content	5 Large Drug Stocks to Watch From a Thriving Industry May 31 / Zacks.com - Paid Partner Content
Biogen (BIIB) to End One of Two Parkinson's Studies on BIIB122 Jun 06 / Zacks.com - Paid Partner Content	The Best Stocks to Invest $5,000 in Right Now May 31 / MotleyFool.com - Paid Partner Content
Moderna (MRNA), Merck's Cancer Jab Delays Melanoma Spreading Jun 06 / Zacks.com - Paid Partner Content	Brokers Suggest Investing in Novo Nordisk (NVO): Read This Before Placing a Bet May 30 / Zacks.com - Paid Partner Content
Novartis Announces Positive Data on Breast Cancer Drug Kisqali Jun 05 / Zacks.com - Paid Partner Content	Better Dividend Stock: Eli Lilly or Novo Nordisk? May 30 / MotleyFool.com - Paid Partner Content
Oncorus (ONCR) Dips 37% on Layoff Plan & Bankruptcy Threat Jun 05 / Zacks.com - Paid Partner Content	This Pharma's Sales Are So Hot It's Trying to Curb Demand May 30 / MotleyFool.com - Paid Partner Content